Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LYEL — Lyell Immunopharma, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$112,470
+$109,963 QoQ
Shares Held
8,005
+6304.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 87 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. LYEL ranks #283 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in LYEL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,470 8,005
2026-03-31 $2,507 125
2025-12-31 $3,847 125
2025-06-30 $17,414 1,970
2025-03-31 $51,891 96,453
2024-12-31 $60,364 94,320
2024-09-30 $101,813 73,778
2024-06-30 $102,380 70,607
2024-03-31 $136,571 61,243
2023-12-31 $103,543 53,373
2023-09-30 $176,485 120,058
2023-06-30 $383,902 120,724
2023-03-31 $270,939 114,805
2022-09-30 $11,412 1,557
2022-06-30 $7,876 1,208
2022-03-31 $45,843 9,078
2021-12-31 $371 48
2021-09-30 $1,909 129